On June 2, 2021, the Board of Sierra Oncology, Inc. reassigned Robert Pelzer from the Audit Committee to the Nominating and Corporate Governance Committee; and reassigned Craig Collard from the Nominating and Corporate Governance Committee to the Compensation Committee.